Assessment of the Quality of Life in Psychoactive Substance Addicts Test: Reliability and validity studies;Test para la Evaluación de la Calidad de Vida en Adictos a Sustancias Psicoactivas (TECVASP): Estudios de fiabilidad y validez

Trastornos Adictivos

Volumn 9, Issue 2, 2007, Pages 97-107

  Lozano Rojas, O M ^a,b   Rojas Tejada, A ^c   Perez Melendez C ^d   Apraiz Granados, B ^a   Sanchez Munoz F ^a   Marin Bedoya A ^a  

^a Fundacion Andaluza para la Atencion a Las Drogodependencias e Incorporacion Social   (Spain)

^b UNIVERSITY OF HUELVA   (Spain)

^c UNIVERSITY OF ALMERÍA   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Health related quality of life; Quality of life; Reliability; Test; Validity

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CRONBACH ALPHA COEFFICIENT; DRUG DEPENDENCE; DRUG DETOXIFICATION; FEMALE; GROUP THERAPY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RELIABILITY; SUBSTANCE ABUSE; TREATMENT OUTCOME; VALIDATION STUDY;

EID: 37849006229     PISSN: 15750973     EISSN: 15782638     Source Type: Journal    
DOI: 10.1016/S1575-0973(07)75635-0     Document Type: Article

References (46)

1. Bowling A. Measuring illness: A review of disease specific quality of life measurement scales. Philadelphia: Open University Press; 1994.
2. Reno RR, Aiken LS. Life activities and life quality of heroin addicts in and out of methadone treatment. Int J Addiction. 1993;28:211-32.
3. Sánchez-Hervás E, Tomás V, Molina N, Del Olmo R, Morales E. Procesos de cambio en conductas adictivas: influencia de variables psicopatológicas y de consumo. Adicciones. 2002;14:337-44.
4. Iraurgi I, Póo M, Márkez I. Valoración del índice de salud SF-36 aplicado a usuarios de programas de metadona. Valores de referencia para la Comunidad Autónoma Vasca. Rev Esp Salud Pública. 2004;78:609-21.
5. Fernández Miranda JJ, González MP, Sáiz PA, Gutiérrez E, Bobes J. Calidad de vida y severidad de la adicción en heroinómanos en mantenimiento prolongado con metadona. Adicciones. 1999;11:43-52.
6. Ventegodt S, Merrick J. Psychoactive drugs and quality of life. Scientific World Journal. 2003;3:694-706.
7. Dalgar O, Egeland A, Skaug K, Vilimas K, Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology. 2004;39:74-80.
8. Posner G, Lecusay R, Miguez-Burbano MJ, Quesada J, Rodríguez A, Ruiz P, et al. Quality of life measures in the Miami HIV-1 infected drug abusers cohort: relationship to gender and disease status. J Subst Abuse. 2000;11:395-404.
9. Giacomuzzi SM, Riemer Y, Ertl M, Kemmler G, Rösler H, Hinterhuber H, et al. Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment. Addiction. 2003;98:693-702.
10. Giacomuzzi SM, Ertl M, Kemmler G, Riemer Y, Vigl A. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment. Scientific World Journal. 2005;5:452-68.
11. Iraurgi I, Casas A, Velorio MJ, Díaz-Sanz M. Calidad de vida relacionada con la salud en usuarios de un programa de metadona. Rev Esp Salud Pública. 1999;24:131-47.
12. Iraurgi I. Estimación de la calidad de vida en toxicomanías mediante el cuestionario MOS-SF-35: estructura factorial, consistencia interna y validez. Rev Esp Drogodependencias. 1999;24:31-45.
13. Iraurgi I. La calidad de vida como indicador de resultados en la clínica en drogodependencias; 2004. Disponible en: http://www.ieanet.com/ boletin/opinion.html?o=25
14. Vanagas G, Padaiga Z, Subata E. Drug addiction maintenance treatment and quality of life measurement. Medicina (Kaunas). 2004;40:833-41.
15. Iraurgi I. Valoración del estado de salud como calidad de vida. Aplicación de la matriz de Rosser en toxicomanías. Rev Esp Drogodependencias. 2002;27:562-73.
16. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I conceptual framework and item selection. Med Care. 1992;30:473-83.
17. Hunt SM, McEwen J, McKenna SP. Measuring health stats: a new tool for clinicians and epidemiologists. J Royal Coll Gen Pract. 1985;35:185-8.
18. Torrens M, San L, Martínez A, Castillo C, Domingo-Salvany A, Alonso J. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction. 1997;92:707-16.
19. Lawton MP, Winter L, Kleban MH, Ruckdeschel K. Affect and quality of life: Objective and subjective. J Aging Health. 1999;11:169-99.
20. Rodríguez-Marín J, Pastor MA, López-Roig S. Afrontamiento, apoyo social, calidad de vida y enfermedad. Psicothema. 1993;5 Supl:349-72.
21. Corrales E, Tardón A, Cueto A. Estado funcional y calidad de vida en mayores de setenta años. Psicothema. 2000;12:171-5.
22. Wilson M, Cleary P. Linking clinical variables with health related quality of life. JAMA. 1995;273:59-65.
23. American Psychiatric Association. Manual diagnóstico y estadístico de los trastornos mentales. Barcelona: Masson; 1994.
24. Foster JH, Marshall EJ, Hooper RL, Peters TJ. Measurement of quality of life in alcohol-dependent subjects by a cancer symptoms checklist. Alcohol. 2000;20:105-10.
25. Gill T. Heroin Addiction. GP Drug & Alcohol Supplement [revista en internet]. 1997; Suppl 8. Disponible en: www.health.nsw.gov.au/publichealth/dpb/ supplements/supp8.pdf
26. Rosser RM. Quality of life: assessment and application. Lancaster: MTP Press; 1988.
27. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and Chronic Fatigue Syndrome: A prospective study in the primary care setting. Am J Psychiatry. 1996;153:1050-9.
28. Stuifbergen AK, Seraphine A, Roberts G. An explanatory model of health promotion and quality of life in chronic disabling conditions. Nurs Res. 2000;49:122-30.
29. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Arch Gen Psychiatry. 1992;39:151-6.
30. Sofuoglu M, Brown S, Babb DA, Hatsukami DK. Depressive symptoms modulate the subjective and physiological response to cocaine in humans. Drug Alcohol Depend. 2001;63:131-7.
31. Strain EC, Stitzer ML, Bigelow GE. The early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis. 1991;179:215-21.
32. Calvo H. Alcohol y neuropsicología. Trastornos Adictivos. 2003;5:256-68.
33. Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction. 2000;95:687-96.
34. Gillen RW, Kranzler HR, Bauer LO, Burleson JA, Samarel D, Morrison DJ. Neuropsychologic findings in cocaine-dependent outpatients. Progress Neuropsychopharm Biol Psychiatry. 1998;22:1061-76.
35. Ryan R. Attentional bias and alcohol dependence: A controlled study using the modified Stroop paradigm. Addict Behav. 2002;27:471.
36. Cox DR, Fitzpatrick R, Fletcher AE, Gore SM, Spiegelhalter DJ, Jones DR. Quality of Life assessment: can we keep it simple? J R Stat Soc. 1997;155:353-93.
37. Bisconti TL, Bergeman CS. Perceived social control as a mediator of the relationships among social suport, psychological well-being, and perceived health. Gerontologist. 1999;39:94-103.
38. Lin N, Simeone RS, Ensel WM, Kuo W. Social support, stressful life events, and illness: A model and an empirical test. J Health Soc Behav. 1979;20:108-19.
39. Wasserman DA, Stewart AL, Delucchi KL. Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug Alcohol Depend. 2001;65:65-75.
40. Fernández C, Torres MA. Evaluación de resultados del tratamiento: el Maudsley Addiction Profile. En: Iraurgi J, González-Saiz F, editores. Instrumentos de evaluación en drogodependencias. Madrid: Aula Médica Ediciones; 2002. p. 387-400.
41. American Psychological Association, American Educational Research, National Council on Measurement in Education. Standards for educational and psychological testing. Washington, DC: American Psychological Association; 1999. Disponible en: http://www.apa.org/science/standards.html.
42. Dirección General para las Drogodependencias y Adicciones. Catálogo de los servicios asistenciales de los centros de tratamiento ambulatorio de Andalucía. Sevilla: Junta de Andalucía; 2003.
43. Ware J. Conceptualization and measurement of health-related quality of life: comments on an envolving field. Arch Phys Med Rehabil. 2003;84 Suppl 2:S43-52.
44. Badía X. La investigación de resultados en salud: de la evidencia a la práctica clínica. Barcelona: Edimac; 2000.
45. Herdman M. Medida de la calidad de vida relacionada con la salud. Med Clín (Barc). 2000;114 Supl 3:S22-5.
46. Prieto L, Badía X. Cuestionarios de salud: concepto y metodología. Aten Primaria. 2001;28:201-9.